This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA approves pioneering CAR-T cancer gene therapy
The FDA grants historic approval for CAR-T cell therapy, the first gene therapy in the U.S. market. Novartis charges 475000 dollars for a one time infusion, with financial aid options and centers nationwide to administer the treatment to ALL patients, while researchers warn durability and access remain questions.
MENTIONED IN THIS ARTICLE
Washington
U.S
Food and Drug Administration
Novartis Pharmaceuticals
FDA
Scott Gottlieb
Novartis
University of Pennsylvania
Ted Laetsch
University of Texas Southwestern Medical Center
Sekeres
Cleveland Clinic
Novar
Grupp
Penn
Carl June
Kite Pharma
National Cancer Institute
Juno Therapeutics
David Maloney
Fred Hutchinson Cancer Research Center
Seattle
Juno